APA (7th ed.) Citation

S, M., L, W., M, T., & K, H. (2025). Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders. The international journal of neuropsychopharmacology, 28(9), . https://doi.org/10.1093/ijnp/pyaf055

Chicago Style (17th ed.) Citation

S, Mohammad, Wang L, Torii M, and Hashimoto-Torii K. "Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders." The International Journal of Neuropsychopharmacology 28, no. 9 (2025). https://doi.org/10.1093/ijnp/pyaf055.

MLA (9th ed.) Citation

S, Mohammad, et al. "Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders." The International Journal of Neuropsychopharmacology, vol. 28, no. 9, 2025, https://doi.org/10.1093/ijnp/pyaf055.